Inhibitory G (G i ) proteins have been proposed to be cardioprotective. We investigated effects of Ga i2 knockout on cardiac function and survival in a murine heart failure model of cardiac b 1 -adrenoceptor overexpression.
Introduction
Norepinephrine concentrations and sympathetic drive are increased in human heart failure. 1 -3 Although this helps to maintain contractile force, blood pressure, and blood flow to vital organs, it becomes detrimental in the long run. with stimulatory G proteins (G s ), whereas b 2 -adrenoceptors have been shown to directly interact with both G s and inhibitory G (G i ) proteins. 6, 7 In human heart failure, expression of sarcolemmal b 1 -adrenoceptors and their coupling with G s decreases. 8 On the other hand, an increase of 'promiscuous' b 2 -relative to b 1 -adrenoceptors and an increased expression of G i (particularly the isoform G i2 ) are observed. 8, 9 This latter finding can be interpreted as an attempt to shield the heart against catecholamines since Rau et al. 10 have shown that a G i2 increase similar to that found in human heart failure is sufficient to significantly reduce adenylyl cyclase-mediated cAMP production. This and other findings support the hypothesis that signalling via G i proteins is cardioprotective. 11 -14 Of interest, overexpression of both b 1 -and b 2 -adrenoceptors has been shown to induce cardiac hypertrophy and heart failure in mice, respectively. 15, 16 However, levels of overexpression necessary to cause heart failure seem to be higher for b 2 -adrenoceptors that in contrast to b 1 -adrenoceptors couple with both G s and G i . 15, 16 Nonetheless, cardioprotective effects mediated by G i proteins are still a matter of debate, particularly regarding the cardiac condition, e.g. normal vs. pathological. To address this issue, we investigated whether lack of the catalytic G i2 subunit (Ga i2 ) affects cardiac function and survival in the murine heart failure model of cardiac b 1 -adrenoceptor overexpression compared with wild-type mice and mice either lacking Ga i2 or overexpressing b 1 . Parts of this work have already been published as a conference abstract. 17 2. Methods
Mouse models used
Animals were kept in individually ventilated cages with a 12/12 h dark/light cycle and food and water ad libitum. Mice ubiquitary lacking Ga i2 (Ga i2 2/2 ) have originally been generated on a 129Sv background, but subsequently been backcrossed to C57BL/6J. 13, 18, 19 Mice with a cardiac-specific overexpression of the human b 1 -adrenoceptor (b 1 -tg) have originally been generated on a FVB/N background. 15 For the current study, we backcrossed this line on a C57BL/6J background (.10 generations) to allow for mating with Ga i2 knockout mice to generate b 1 -transgenic animals deficient of Ga i2 2/2 (b 1 -tg/ Ga i2 2/2 ). As control animals we used age-matched wild-type littermates. Animals of both sexes were used for our study. For genotyping, tail-clips from 3-week-old mice were used. Genomic DNA was prepared and genotyping PCR for Ga i2 and the b 1 -receptor was performed as described previously. 13, 20 Animals were killed by cervical dislocation. Animal breeding, maintenance, and experiments were approved by the responsible federal state authority (Landesamt fuer Natur-, Umwelt-und Verbraucherschutz Nordrhein-Westfalen; reference: 87-51.04.2010.A078). All animal experiments comply with the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.
Survival analysis
All genotypes were monitored for a minimum period of 2 years. KaplanMeier survival curves were used to determine mean survival time of each mouse line. Spontaneous death was defined as the event of interest, while killing an animal was a censored event. Mice used for breeding were excluded from our analysis. Numbers of mice included in our survival analysis were 200, 34, 37, and 192 for C57BL/6 (wild type), Ga i2 2/2 , b 1 -tg/Ga i2 2/2 , and b 1 -tg mice, respectively. Numbers of spontaneous deaths that occurred during an observation period were 9 (C57BL/6), 10 (Ga i2 2/2 ), 21
(b 1 -tg/Ga i2 2/2 ), and 22 (b 1 -tg).
Echocardiography
At an age of 302 + 19 days, mice (n ¼ 5-7 of every genotype) were examined by echocardiography under light inhalation anaesthesia with oxygen and 1.5% isoflurane through a nose cap. Chests were epilated and the animals were placed on a heating table to prevent hypothermia and cardiodepressive effects. For the experiments, a commercial echocardiography system (Philips iE33 ultrasonic system, 'Qlab Cardiac Analysis' Software; Philips Healthcare, Hamburg, Germany) equipped with a 15 MHz linear array transducer (L15-io7) allowing frame rates of 270 Hz was used. The transducer was moved along the parasternal long and short axis of the left ventricle, and loops of 3 s duration were recorded in one-dimensional (M-mode) and two-dimensional planes. To monitor the heart rate of the animals and thus anaesthesia during measurements, an ECG was derived. For reconstructive three-dimensional echocardiography, multiple short-axis slices were recorded every 500 mm using a millimetre screw-tripod.
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Ventricle-to-body weight ratio
Before killing a mouse, its body weight was measured. For determining ventricular weight, hearts were excised immediately after killing by cervical dislocation, atria were cut, and intraventricular blood removed. We analysed 11, 8, 7 , and 14 hearts of C57BL/6 (wild-type), Ga i2 2/ 2 , b 1 -tg/ Ga i2 2/2 , and b 1 -tg mice, respectively, including those from mice examined by echocardiography. 
Quantitative real-time PCR
Western blot analysis
Ventricles from three different animals per genotype were isolated, separately homogenized, and individually analysed. Tissue was homogenized in protein lysis buffer containing 21 mM Tris -HCl, pH 8.3, 0.67% SDS, 238 mM b-mercapoethanol, and 0.2 mM PMSF. Ga protein isoform separation was performed in gels containing 6 M urea. In total, 20 mg per lysate was loaded. To verify Ga i3 antibody specificity, ventricle lysates isolated from Ga i3 -deficient mice were loaded. 26 The proteins were visualized by immunodetection using the following primary antibodies described elsewhere: 27 -30 rabbit anti-Ga i2 (1 : 8000) and rabbit anti-Ga i3 (1 : 5000).
Equal loading was verified with antibodies against rabbit anti-b-actin (1 : 10 000). The protein levels of Ga i2 and Ga i3 were quantified using the densitometric analysis software (Image Lab; Bio-Rad, Gräfelfing, Germany) and were normalized to the b-actin levels of the same samples.
For each ventricle, immune blots were run in triplicates or quadruplicates.
Homogenates of the four different genotypes were always loaded on the same gel and analysed in parallel.
Lack of Ga i2 in b1-adrenoceptor overexpressing mice
Radioligand-binding experiments
Hearts from 4-to 6-month-old mice of both sexes were isolated in ice-cold phosphate buffer saline, frozen in liquid nitrogen, and stored at 2808C until membrane preparation. Ventricular tissue was homogenized in a 0.32 M sucrose solution and centrifuged for 11 min at 300 × g. Supernatants were centrifuged for 41 min at 80 000 × g and pellets resuspended in aqua destillata. All preparation steps were carried out at 48C. Finally, aliquots of 0.5 mL were frozen in liquid nitrogen and stored at 2808C. ]N-methylscopolamine (specific activity: 84.1 Ci/mmol; PerkinElmer). Binding curves were analysed by nonlinear curve fitting using the software GraphPad Prism w . Data points were fitted by a one-site-specific binding model.
Statistical analysis
Data are given as mean + S.E.M. Survival times were calculated by KaplanMeier estimation. Differences were determined by the log-rank test. Cardiac functional parameters obtained from echocardiography and ventricle-to-body weight ratios were compared by ANOVA followed by post hoc tests (Bonferroni). mRNA expression ratios using C t values obtained by qPCR were compared using the REST-2009 w software. 31 Distribution between sexes was compared by Fisher's exact test. P-values ,0.05 were defined to indicate statistically significant differences.
Results
Gross phenotype
Genotypes were distributed as expectable according to the Mendelian law (not shown). Overall distribution between sexes was nearly equal (51% male and 49% female) and did not differ between genotypes (not shown). All mice behaved normally and no overt phenotype was observed. Deaths occurred suddenly and were only in single cases preceded by unspecific symptoms like reduced movement or seclusive behaviour. Gastrointestinal symptoms as described previously for mice lacking Ga i2 were not seen in our study, presumably due to keeping the mice in individually ventilated cages. (Figure 2 ). This was confirmed in echocardiographic examinations of anaesthetized mice of the same age. Ventricles of b 1 -tg/Ga i2 2/2 mice appeared to be clearly enlarged (see Supplementary material online, Figure S1 ). End-systolic and end-diastolic ventricular volumes were similar when comparing wild-type, Ga i2 2/2 , and b 1 -tg mice, but significantly (Figures 2, 3, 5-7 ).
K Figure 3A and B) . Furthermore, ejection fraction was significantly reduced in b 1 -tg/Ga i2 2/2 mice ( Figure 3C ). Significantly increased ventricular length and reduced myocardial thickness in b 1 -tg/Ga i2 2/ 2 mice indicated a dilative cardiomyopathy (data not shown; compare Supplementary material online, Figure S1 ).
3. 
Expression of G i proteins
Expression of Ga i2 mRNA was not detectable in Ga i2 knockout mice ( Figure 5A ). We found that the lack of Ga i2 was accompanied by an increased expression of Ga i3 mRNA, both on a wild-type and on a b 1 -transgenic background ( Figure 5B) . Expression of neither Ga i2 nor Ga i3 mRNA was significantly altered in hearts of mice being only transgenic for the b 1 -adrenoceptor. Immunoblot analysis of ventricle Lack of Ga i2 in b1-adrenoceptor overexpressing mice homogenates revealed Ga i2 protein expression in ventricles of C57BL/ 6 and b 1 -tg mice, whereas the Ga i2 protein was absent in Ga i2 2/2 and b 1 -tg/Ga i2 2/2 ventricles ( Figure 5C and E). Ga i3 protein levels were significantly up-regulated in Ga i2 2/ 2 (340 + 90%) and b 1 -tg/Ga i2
2/ 2
(394 + 80%) ventricles compared with C57BL/6 and b 1 -tg animals and absent in Ga i3 -deficient ventricles ( Figure 5D and F ).
Expression of hypertrophy markers and PKA targets
According to our morphological and functional findings, qPCR analysis revealed a significant up-regulation of the cardiomyopathy markers ANP ( Figure 6A ) and BNP ( Figure 6B ) in ventricular tissue of b 1 -tg/ Ga i2 2/2 compared with wild-type mice. However, mRNA expression levels of ANP were also significantly increased in Ga i2 2/ 2 mice and showed a tendency to be higher in b 1 -tg animals ( Figure 6A ). BNP levels were unchanged in Ga i2 2/2 , but significantly increased in b 1 -tg mice ( Figure 6B ). We tested for mRNA expression of the calcium release channel (ryanodine receptor) RYR2, the cardiac TnI TNNI3, and PLB as known targets of PKA-mediated phosphorylation ( Figure 7) . Compared with C57BL/6 wild-type mice, no differences were seen for RYR2 mRNA, but there was a significantly reduced expression of TnI in ventricles of b 1 -tg/Ga i2 2/2 (63 + 7% of wild type), and of PLB in ventricles of both b 1 -tg and b 1 -tg/Ga i2 2/2 (43 + 6 and 47 + 12% of wild type, respectively).
Discussion
In line with the idea of cardioprotective signalling mediated by G i proteins, we show here that the lack of Ga i2 in mice overexpressing cardiac b 1 -adrenoceptors was detrimental: cardiac contractility was significantly depressed and survival time dramatically reduced. Mice deficient for either Ga i2 or Ga i3 have been reported to have no overt cardiac phenotype in vivo (echocardiography) and ex vivo (isolated whole hearts and myocytes). 34 This is in perfect agreement with our current data obtained from Ga i2 -deficient mice in the same range of age. Survival time of Ga i2 -deficient mice was reduced, but reduction was significantly more pronounced in b 1 -tg/Ga i2 2/2 mice. Of interest, survival curves of b 1 -tg/Ga i2 2/2 and mice only lacking Ga i2 were indistinguishable up to an age of 300 days. Since survival curves of b 1 -tg mice start to drop rather late (this study and Lee et al.
33
), it is tempting to speculate that the early effect on mortality (up to Day 300) is due to Ga i2 deficiency while the detrimental effect observed beyond 300 days of age is related to the cardiac overexpression of b 1 -adrenoceptors. Given that cardiac function of mice only lacking Ga i2 was unaffected at an age of 300 days, a cause of death other than reduced pump function has to be supposed. In a previous study, mice with both a Ga i2 knockout and a cardiac-specific overexpression of b 2 -adrenoceptors have been shown to be not viable. 13 This fatal outcome might be explained by direct coupling of b 2 -adrenoceptors to G i proteins. The drastic effect of Ga i2 deficiency on top of cardiac b 1 -adrenoceptor overexpression seen in our current study is rather surprising given that b 1 -adrenoceptors are thought to exclusively couple with G s proteins. However, recent work suggests a role for G i in modulation of b 1 -mediated effects. Melsom et al. 35 showed that inhibition of G i proteins by pertussis toxin (PTX) not only enhanced cAMP accumulation following selective stimulation of either b 1 -or b 2 -adrenoceptors, but also increased inotropic potency of b 1 -and b 2 -adrenergic agonists, respectively. Another work by the same group indicates that G i exerts intrinsic receptor-independent inhibitory activity on adenylyl cyclase. 36 
b 1 -Adrenoceptor overexpression
Like in mice overexpressing the cardiac b 2 -adrenoceptor, the phenotype of b 1 -transgenic mice seems to depend on the extent of overexpression. A higher expression level of b 1 -adrenoceptors led to an earlier and more pronounced hypertrophy of cardiomyocytes and a higher sensitivity of contractile response to dobutamine. 15 We found that after back-crossing on a C57BL/6 background, cardiac b-adrenoceptor overexpression was lower compared with FVB/ N-based b 1 -transgenic mice. This might explain why survival curves of b 1 -transgenic mice on a C57BL/6 background start to drop later (in accordance to findings of another group that independently backcrossed the b 1 -transgeni mice mouse of Engelhardt et al. on a C57BL/6 background). 15, 33 In good agreement, cardiac function was already impaired at an age of 300 days in FVB/N-, but not in C57BL/ 6-based b 1 -transgenic mice.
cAMP-dependent adrenergic signalling
That there was overt cardiomyopathy in (C57BL/6-based) b 1 -transgenic mice additionally lacking Ga i2 thus might be explained by a dual mechanism: increased b 1 -adrenergic drive and lack of protection by Ga i2 . Engelhardt et al. 37 found an increased expression of the cardiac showed that NHE1 inhibition prevented heart failure in this mouse model. Since NHE1 activity is modulated by cAMP, one might speculate that, in the b 1 -overexpression model, lack of Ga i2 further aggravates NHE1-dependent effects leading to accelerated development of cardiac dysfunction and eventually mortality in our study. 38 Though only an indirect hint, we looked at the expression of other potential phosphorylation targets at the mRNA level. Altered phosphorylation of the calcium release channel RYR2 has been attributed to heart failure and cardiac arrhythmia, though there is an ongoing controversial discussion. 39 In our mouse models, RYR2 mRNA expression was unchanged, but we cannot exclude that enhanced phosphorylation due to a maintained increase of b-adrenergic tone might be involved in the early mortality we observed in b 1 -transgenic mice lacking Ga i2 . TnI seems to mediate both lusitropic and inotropic responses following b-adrenergic stimulation in murine hearts, 40 though the role of TnI and its phosphorylation in healthy and failing hearts is matter of debate. 41 We found a significant reduction of TnI expression at the mRNA level in b 1 -transgenic mice lacking Ga i2 . This might be related to their detrimental outcome since it has been shown that TnI knockout leads to heart failure in adult mice. 42 Both b 1 -transgenic mouse lines investigated in our study (b 1 -tg and b 1 -tg/Ga i2 2/2 ) showed a significant reduction of PLB mRNA expression. Engelhardt et al. 43 found no alteration of PLB expression in b 1 -transgenic mice at an age of 2 months, but an increased PLB phosphorylation indicating enhanced b-adrenergic signalling. The decrease of PLB expression observed at an age of 9-10 months in our study might be compensatory by restoring the function of the SR calcium pump SERCA2A. 44 Indeed, knockout of PLB in b-transgenic mouse hearts has been shown to rescue its heart failure phenotype. 45 However, there seems to be a critical difference between mice and men because human PLB null has been shown to result in lethal cardiomyopathy. 46 Of note, PKA-dependent phosphorylation of b 2 -adrenoceptors has been shown to drive a switch from G s to G i signalling, 47 though this mechanism is matter of Lack of Ga i2 in b1-adrenoceptor overexpressing mice debate. b 1 -Adrenoceptor overexpression thus might enhance b 2 -adrenoceptor-mediated G i signalling. This would explain the pronounced effect of Ga i2 deficiency in b 1 -transgenic mice compared with mice with an otherwise wild-type background seen in our study.
G i -mediated adrenergic signalling
Irrespective of the (disputed) role of b 2 -adrenoceptor regulation by b 1 -adrenoceptors, the accepted role of G i proteins for b 2 -adrenoceptor signalling should be considered. Communal et al. 48 have described opposing b-adrenoceptor-mediated effects on apoptosis in rat cardiomyocytes in terms of enhancement via b 1 -but attenuation via b 2 -adrenoceptors. Indeed, the combination of b 1 -adrenoceptor blockers and b 2 -adrenoceptor agonists has been shown to be superior to only b 1 -adrenoceptor antagonists in treating cardiomyopathy in rodents. 49, 50 Though the above-mentioned anti-apoptotic effect by b 2 -adrenergic signalling was attributed to G i -dependent activation of p38, the finding that overexpression of a dominant negative p38 isoform rescued cardiomyopathy of b 2 -but not b 1 -adrenoceptor transgenic mice argues against a role of this mechanism in our study. 51, 52 Kohler et al. 14 have recently shown that following an ischaemia/reperfusion (I/R) protocol, cardiac infarct size was significantly increased in mice deficient for Ga i2 . Also in a murine I/R model, similar findings have been obtained with an induced cardiac expression of a G i inhibitor peptide. 11 Taken together with our current study on b 1 -adrenoceptor overexpressing mice, these data suggest that the cardioprotective role of G i proteins might become evident under certain circumstances only, i.e. cardiac stress and/or disease. Not all studies support the idea of G i proteins being protective in cardiomyopathy and heart failure. The beneficial effect of combined treatment with a b 1 -adrenoceptor blocker and a b 2 -adrenoceptor agonist following myocardial infarction in rats was also seen when using fenoterol that has been shown to mediate b 2 -adrenergic effects independent of G i proteins. 50, 53 Of note, the expression was significantly reduced compared with wild-type (C57BL/6) tissue. The number of animals used for analysis was 3 -4 for each genotype. Age range of examined mice was 288 + 9 days. Asterisks indicate significant differences compared with mRNA expression levels of age-matched wild-type mice in an REST w analysis (*P , 0.05).
reported G protein selectivity of stereoisomers of fenoterol has recently been challenged. 54 In a mouse model of dilative cardiomyopathy due to cre-recombinase overexpression, an increase of G i signalling by knock-in of a mutated Ga i2 did not improve but even worsen ventricular hypertrophy and mortality. 55 In a pathophysiologically more relevant model, Hussain et al. 56 found no change in G i activity in rat heart failure following myocardial infarction: despite a significant increase of Ga i2 protein by 50% G i inhibition by PTX treatment, here did neither change baseline contractility nor inotropic response following b-adrenergic stimulation in ventricular strips from failing hearts.
Role of G i2 vs. G i3
The putative differential roles of the most abundant cardiac G i isoforms Ga i2 and Ga i3 are still a matter of debate. As mentioned above, mice with cardiac-specific overexpression of b 2 -adrenoceptors were not viable, if they in addition were deficient of Ga i2 . 13 In the same study, heterozygous knockout of Ga i2 in b 2 -transgenic mice caused a reduced activity of ventricular L-type Ca 2+ channels that was attributed to an increased expression of Ga i3 . These data led us to the hypothesis that Ga i2 is cardioprotective, whereas Ga i3 is rather of regulatory relevance. In a subsequent study, this hypothesis was supported by our finding that, in Ga i2 knockout mice, cardiac Ga i3 expression was up-regulated and accordingly ventricular Ca 2+ -current density was decreased while, in mice lacking Ga i3 , Ca 2+ -current density was enhanced despite an increased Ga i2 expression. 24 Kohler et al. 14 confirmed an increased cardiac Ga i2 expression in mice lacking Ga i3 and found ventricular infarct size following ischaemia to be reduced here compared with wild-type mice or mice lacking Ga i2 .
Conclusion
In conclusion, our data support the idea of the G i protein Ga i2 to be cardioprotective. Of interest, this was observed in b 1 -adrenoceptor overexpressing mice, i.e. a mouse model of cardiac stress not directly involving G i signalling. The lack of Ga i2 seemed to aggravate rather than cause cardiac dysfunction. The observed up-regulation of Ga i3 was not sufficient to compensate for Ga i2 deficiency, suggesting an isoformspecific or a concentration-dependent mechanism to be elucidated in further studies.
